Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma

Jurriaan B. Tuynman, Christianne J. Buskens, Kristel Kemper, Fiebo J W Ten Kate, G. Johan A Offerhaus, Dirk J. Richel, J. Jan B Van Lanschot, [No Value] Lerut, [No Value] Eggermont, [No Value] Lundell

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences